Evaluation of anti-colitic effect of fluvoxamine against acetic acid-induced colitis in normal and reserpinized depressed rats

European Journal of Pharmacology

Volumn 746, Issue , 2015, Pages 293-300

  Minaiyan, Mohsen ^a   Hajhashemi, Valiollah ^a   Rabbani, Mohammad ^a   Fattahian, Ehsan ^b   Mahzouni, Parvin ^c  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHREKORD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colitis; Depressive disorders; Fluvoxamine; Rat; Reserpine

Indexed keywords

ACETIC ACID; DEXAMETHASONE; FLUVOXAMINE MALEATE; MYELOPEROXIDASE; RESERPINE; ANTIDEPRESSANT AGENT; FLUVOXAMINE; GASTROINTESTINAL AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTI COLITIC EFFECT; ANTIDEPRESSANT ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; COLON INJURY; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE COURSE; DISEASE SEVERITY; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME ASSAY; FORCED SWIM TEST; HISTOPATHOLOGY; INFLAMMATORY BOWEL DISEASE; MALE; NONHUMAN; RAT; TREATMENT DURATION; WEIGHT CHANGE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; COLITIS, ULCERATIVE; COLON; COMPARATIVE STUDY; COMPLICATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; DRUG RESISTANCE; ENZYMOLOGY; IMMUNOLOGY; INTESTINE MUCOSA; METABOLISM; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PSYCHOLOGY; RANDOMIZATION; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIPSYCHOTIC AGENTS; COLITIS, ULCERATIVE; COLON; DEPRESSION; DEXAMETHASONE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; FLUVOXAMINE; GASTROINTESTINAL AGENTS; INTESTINAL MUCOSA; MALE; NEUTROPHIL INFILTRATION; PEROXIDASE; RANDOM ALLOCATION; RATS, WISTAR; RESERPINE;

EID: 84916899041     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.11.016     Document Type: Article

References (48)

1. O.M. Abdel-Salam, A.R. Baiuomy, and M.S. Arbid Studies on the anti-inflammatory effect of fluoxetine in the rat Pharmacol. Res. 49 2004 119 131
2. F. Aricioʇlu, U. Buldanlioʇlu, G. Salanturoʇlu, and N.S. Ozyalçin Evaluation of antinociceptive and anti-inflammatory effects of venlafaxine in the rat Agri 17 2005 41 46
3. C. Bernstein, M. Fried, J.H. Krabshuis, H. Cohen, R. Eliakim, S. Fedail, and R. Gearry Inflammatory bowel disease: a global perspective World J. Gastroenterol. 28 2009 1 24
4. S. Bolandghamat, A. Moghimi, and M. Iranshahi Effects of ethanolic extract of pine needles (Pinus eldarica Medw.) on reserpine-induced depression-like behavior in male Wistar rats Pharmacogn. Mag. 7 2011 248 253 10.4103/0973-1296.84240
5. P.P. Bradley, D.A. Priebat, R.D. Christensen, and G. Rothstein Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker J. Invest. Dermatol. 78 1982 206 209
6. C.D. Deshmukh, B. Veeresh, and A.T. Pawar Protective effect of Emblica officinalis fruit extract on acetic acid induced colitis in rats J. Herb. Med. Toxicol. 4 2010 83 87
7. L.A. Dieleman, M.J. Palmen, H. Akol, E. Bloemena, A.S. Peña, S.G. Meuwissen, and E.P. Van Rees Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines Clin. Exp. Immunol. 114 1998 385 391
8. G. Fakhfouri, R. Rahimian, A. Daneshmand, A. Bahremand, M.R. Rasouli, A.R. Dehpour, S.E. Mehr, and K. Mousavizadeh Granisetron ameliorates acetic acid-induced colitis in rats Hum. Exp. Toxicol. 29 2010 321 328 10.1177/0960327110362702
9. B.R. Filipovic, and B.F. Filipovic Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease World J. Gastroenterol. 20 2014 3552 3563 10.3748/wjg.v20.i13.3552
10. J.J. Galligan 5-hydroxytryptamine, ulcerative colitis, and irritable bowel syndrome: molecular connections Gastroenterology 126 2004 1897 1899
11. J.E. Ghia, P. Blennerhassett, and S.M. Collins Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression J. Clin. Invest. 118 2008 2209 2218 10.1172/JCI32849
12. J.E. Ghia, P. Blennerhassett, Y. Deng, E.F. Verdu, W.I. Khan, and S.M. Collins Reactivation of inflammatory bowel disease in a mouse model of depression Gastroenterology 136 2009 2280 2288
13. M. Ghosh, X. Song, G. Mouneimne, M. Sidani, D.S. Lawrence, and J.S. Condeelis Cofilin promotes actin polymerization and defines the direction of cell motility Science 304 2004 743 746
14. L.A. Graff, J.R. Walker, and C.N. Bernstein Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management Inflamm. Bowel Dis. 15 2009 1105 1118 10.1002/ibd.20873
15. A.A. Guemei, N.M. El Din, A.M. Baraka, and I. El Said Darwish Do desipramine [10,11-dihydro-5-[3-(methylamino) propyl]-5H-dibenz[b,f]azepine monohydrochloride] and fluoxetine [N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-propan-1-amine] ameliorate the extent of colonic damage induced by acetic acid in rats? J. Pharmacol. Exp. Ther. 327 2008 846 850 10.1124/jpet.108.141259
16. W. Häuser, C. Schmidt, and A. Stallmach Depression and mucosal proinflammatory cytokines are associated in patients with ulcerative colitis and pouchitis - A pilot study J. Crohns. Colitis. 5 2011 350 353
17. V. Hajhashemi, H. Sadeghi, M. Minaiyan, A. Movahedian, and A. Talebi Central and peripheral anti-inflammatory effects of maprotiline on carrageenan-induced paw edema in rats Inflamm. Res. 59 2010 1053 1059 10.1007/s00011-010-0225-1
18. V. Hajhashemi, H. Sadeghi, M. Minaiyan, A. Movahedian, and A. Talebi Effect of fluvoxamine on carrageenan-induced paw edema in rats evaluation of the action sites Iran. J. Pharm. Res. 10 2010 611 618
19. S. Hashioka, P.L. McGeer, A. Monji, and S. Kanba Anti-inflammatory effects of antidepressants: possibilities for preventives against Alzheimer's disease Cent. Nerv. Syst. Agents Med. Chem. 9 2009 12 19
20. T. Hayashi, M. Miyata, T. Nagata, Y. Izawa, and Y. Kawakami Intracerebroventricular fluvoxamine administration inhibited pain behavior but increased Fos expression in affective pain pathways Pharmacol. Biochem. Behav. 91 2009 441 446 10.1016/j.pbb.2008.08.029
21. S. He Key role of mast cells and their major secretory products in inflammatory bowel disease World J. Gastroenterol. 10 2004 309 318
22. D. Hollander Inflammatory bowel diseases and brain-gut axis J. Physiol. Pharmacol. 54 2003 183 190
23. T. Itatsu, A. Nagahara, M. Hojo, A. Miyazaki, T. Murai, M. Nakajima, and S. Watanabe Use of selective serotonin reuptake inhibitors and upper gastrointestinal disease Intern. Med. 50 2011 713 717
24. S.J. Koh, J.M. Kim, I.K. Kim, N. Kim, H.C. Jung, I.S. Song, and J.S. Kim Fluoxetine inhibits NF-κB signaling in intestinal epithelial cells and ameliorates experimental colitis and colitis-associated colon cancer in mice Am. J. Physiol. Gastrointest. Liver Physiol. 301 2011 9 19 10.1152/ajpgi.00267.2010
25. L.M. Kurina, M.J. Goldacre, D. Yeates, and L.E. Gill Depression and anxiety in people with inflammatory bowel disease J. Epidemiol. Community Health 55 2001 716 720
26. M. Kus̈mider, J. Solich, P. Pałach, and M. Dziedzicka-Wasylewska Effect of citalopram in the modified forced swim test in rats Pharmacol. Rep. 59 2007 785 788
27. B.R. MacPherson, and C.J. Pfeiffer Experimental production of diffuse colitis in rats Digestion 17 1978 135 150
28. J.D. Mikkelsen, A. Hay-Schmidt, and A. Kiss Serotonergic stimulation of the rat hypothalamo-pituitary-adrenal axis: interaction between 5-HT1A and 5-HT2A receptors Ann. NY Acad. Sci. 1018 2004 65 70
29. A.A. Mikocka-Walus, A.L. Gordon, B.J. Stewart, and J.M. Andrews The role of antidepressants in the management of inflammatory bowel disease (IBD): a short report on a clinical case-note audit J. Psychosom. Res. 72 2012 165 167 10.1016/j.jpsychores.2011.06.006
30. A.A. Mikocka-Walus, A.L. Gordon, B.J. Stewart, and J.M. Andrews A magic pill? A qualitative analysis of patients' views on the role of antidepressant therapy in inflammatory bowel disease (IBD) BMC Gastroenterol. 20 2012 12 93
31. A.A. Mikocka-Walus, D.A. Turnbull, N.T. Moulding, I.G. Wilson, J.M. Andrews, and G.J. Holtmann Antidepressants and inflammatory bowel disease: a systematic review Clin. Pract. Epidemiol. Ment. Health 20 2006 2 24
32. A.A. Mikocka-Walus, D.A. Turnbull, N.T. Moulding, I.G. Wilson, J.M. Andrews, and G.J. Holtmann It doesn't do any harm, but patients feel better": a qualitative exploratory study on gastroenterologists' perspectives on the role of antidepressants in inflammatory bowel disease BMC Gastroenterol. 24 2007 7 38
33. A.A. Mikocka-Walus, D.A. Turnbull, N.T. Moulding, I.G. Wilson, G.J. Holtmann, and J.M. Andrews Does psychological status influence clinical outcomes in patients with inflammatory bowel disease (IBD) and other chronic gastroenterological diseases: an observational cohort prospective study? Biopsychosoc. Med. 6 2008 2 11 10.1186/1751-0759-2-11
34. M. Minaiyan, G. Asghari, D. Taheri, M. Saeidi, and S. Nasr Anti-inflammatory effect of Moringa oleifera Lam. seeds on acetic acid-induced acute colitis in rats Avicenna J. Phytomed. 1 2013 1 10
35. M. Minaiyan, A.R. Ghannadi, A.R. Afsharipour, and P. Mahzouni Effects of extract and essential oil of Rosmarinus officinalis L. on TNBS-induced colitis in rats Res. Pharm. Sci. 6 2011 13 21
36. A. Motavallian, M. Minaiyan, M. Rabbani, S. Andalib, and P. Mahzouni Involvement of 5HT3 receptors in anti-inflammatory effects of tropisetron on experimental TNBS-induced colitis in rat Bioimpacts 3 2013 169 176 10.5681/bi.2013.021
37. A. Motavallian, M. Minaiyan, M. Rabbani, and P. Mahzouni Anti-inflammatory effect of ondansetron through 5-HT3 receptors on TNBS-induced colitis in rat EXCLI J. 11 2012 30 44
38. X. Niu, T. Fan, W. Li, H. Huang, Y. Zhang, and W. Xing Protective effect of sanguinarine against acetic acid-induced ulcerative colitis in mice Toxicol. Appl. Pharmacol. 267 2013 256 265
39. R.D. Porsolt, G. Anton, N. Blavet, and M. Jalfre Behavioral despair in rats: a new model sensitive to anti-depressant treatment Eur. J. Pharmacol. 47 1978 379 391
40. A. Prins The brain-gut interaction: the conversation and the implications S. Afr. J. Clin. Nutr. 24 2011 8 14
41. B.S. Qiu, B.A. Vallance, P.A. Blennerhassett, and S.M. Collins The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis Nat. Med. 5 1999 1178 1182
42. B.N. Rajesh, A.T. Fleming, R. Ranvir, R. Sundar, and S. Devada Effect of Tribulus terrestris against Inflammatory Bowel Disease Int. J. Vet. Sci. 2 2013 143 150
43. H. Sadeghi, V. Hajhashemi, M. Minaiyan, A. Movahedian, and A. Talebi A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats Eur. J. Pharmacol. 667 2011 396 401 10.1016/j.ejphar.2011.05.053
44. M.S. Sajadinejad, K. Asgari, H. Molavi, M. Kalantari, and P. Adibi Psychological issues in inflammatory bowel disease: an overview Gastroenterol. Res. Pract. 2012 2012 1 11 10.1155/2012/106502
45. R. Thoreson, and J.J. Cullen Pathophysiology of inflammatory bowel disease: an overview Surg. Clin. North Am. 87 2007 575 585
46. J. Turner, and B. Kelly Emotional dimensions of chronic disease West. J. Med. 172 2000 124 128
47. A.K. Varghese, E.F. Verdú, P. Bercik, W.I. Khan, P.A. Blennerhassett, H. Szechtman, and S.M. Collins Antidepressants attenuate increased susceptibility to colitis in a murine model of depression Gastroenterology 130 2006 1743 1753
48. J. Varshosaz, J. Emami, A. Fassihi, N. Tavakoli, M. Minaiyan, F. Ahmadi, P. Mahzouni, and F. Dorkoosh Effectiveness of budesonide-succinate-dextran conjugate as a novel pro drug of budesonide against acetic acid-induced colitis in rats Int. J. Colorectal Dis. 25 2010 1159 1165